Michio Kato

2.7k citations
104 papers · 1.9k indexed · h-index 22
Topics
Hepatitis C virus research (39 papers)Liver Disease Diagnosis and Treatment (38 papers)Hepatitis B Virus Studies (24 papers)

In The Last Decade

Michio Kato

94 papers receiving 1.8k citations

Peers

Michio Kato
Comparison fields: 5 of 104
  • Epidemiology 1.0k
  • Hepatology 973
  • Molecular Biology 449
  • Immunology 237
  • Surgery 196
Replace Akitaka Shibuya with:
Akitaka Shibuya Japan
Kazuto Tajiri Japan
Pascal Lapierre Canada
Yvon Calmus France
Milton G. Mutchnick United States
Shingo Nakamoto Japan
Claus J. Fimmel United States
Haruhide Shinzawa Japan
Kerstin Herzer Germany
Xavier Verhelst Belgium
Michio Kato relative to Akitaka Shibuya Japan Akitaka Shibuya's profile →
Citations per field
00.5×1.5×
Akitaka Shibuya · 1×
Citations per year

Countries citing papers authored by Michio Kato

Since Specialization
Citations

This map shows the geographic impact of Michio Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michio Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michio Kato more than expected).

Fields of papers citing papers by Michio Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michio Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michio Kato. The network helps show where Michio Kato may publish in the future.

Co-authorship network of co-authors of Michio Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Michio Kato. A scholar is included among the top collaborators of Michio Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michio Kato. Michio Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 17
3 1
4 3
5 11
6 4
7 1
8 0
9 0
10 29
11
Early carcinoma of the gallbladder in a young female resected by laparoscopic cholecystectomy
0
12 1
13 1
14 2
15 0
16 0
17
Antiviral therapy for chronic hepatitis.
8
18 0
19 1
20 1

About Michio Kato

Michio Kato is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 104 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (38 papers) and Hepatitis B Virus Studies (24 papers). The work is most often cited by research in Hepatology (973 citations), Epidemiology (1.0k citations) and Immunology (237 citations). Michio Kato has collaborated with scholars based in Japan, United States and Hong Kong. Frequent co-authors include Akinori Kasahara, Norio Hayashi, Manabu Masuzawa, Naoki Hiramatsu, Tetsuo Takehara, Kazuhiro Katayama, Masahide Oshita, Harumasa Ohyanagi, Nobukazu Yuki and Daisuke Kuroda. Their work appears in journals such as Annals of Internal Medicine, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026